Literature DB >> 11511552

Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion.

T Koike1, S Ohara, H Sekine, K Iijima, Y Abe, K Kato, T Toyota, T Shimosegawa.   

Abstract

BACKGROUND: Helicobacter pylori infection is less prevalent and atrophic gastritis is less extensive in patients with reflux oesophagitis than those without it, but few studies have examined this relationship directly. AIMS: We investigated the relationship between H pylori infection, acid secretion, and reflux oesophagitis in Japanese subjects.
SUBJECTS: A total of 105 patients with erosive reflux oesophagitis were compared with 105 sex and age matched patients without reflux oesophagitis.
METHODS: The diagnosis of H pylori infection was made by histological examination of gastric mucosal biopsy specimens, rapid urease test, and detection of serum IgG antibodies. Acid secretion was assessed by the endoscopic gastrin test.
RESULTS: H pylori infection was present in 36 patients with erosive reflux oesophagitis (34.3%) and in 80 control subjects (76.2%) (odds ratio 0.163, 95% confidence interval 0.09-0.29). Overall acid secretion was significantly greater in patients with reflux oesophagitis. Among H pylori positive patients, acid secretion was greater in patients with reflux oesophagitis than those without oesophagitis.
CONCLUSION: In Japan, erosive reflux oesophagitis occurs most often in the absence of H pylori infection and gastric hyposecretion. Even in the presence of H pylori infection, reflux oesophagitis is more likely to develop in patients without gastric hyposecretion. H pylori infection may inhibit reflux oesophagitis by inducing hypoacidity.

Entities:  

Mesh:

Year:  2001        PMID: 11511552      PMCID: PMC1728422          DOI: 10.1136/gut.49.3.330

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Reflux esophagitis, sliding hiatal hernia, and the anatomy of repair.

Authors:  P R ALLISON
Journal:  Surg Gynecol Obstet       Date:  1951-04

2.  Contribution of HLA-DQA gene to host's response against Helicobacter pylori.

Authors:  T Azuma; J Konishi; Y Tanaka; M Hirai; S Ito; T Kato; Y Kohli
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

3.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

4.  Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.

Authors:  M Newton; R Bryan; W R Burnham; M A Kamm
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

5.  Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis.

Authors:  B F Werdmuller; R J Loffeld
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

6.  Oesophageal acid clearing: one factor in the production of reflux oesophagitis.

Authors:  C Stanciu; J R Bennett
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

7.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

8.  Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.

Authors:  E C Klinkenberg-Knol; J M Jansen; H P Festen; S G Meuwissen; C B Lamers
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

9.  Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux.

Authors:  J Dent; R H Holloway; J Toouli; W J Dodds
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

10.  Clinical and manometric findings in benign peptic strictures of the esophagus.

Authors:  G Ahtaridis; W J Snape; S Cohen
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

View more
  51 in total

1.  Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis.

Authors:  Lun-Hua Chen; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

Review 2.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.

Authors:  José L Calleja; Manuel Suarez; Alberto Herreros De Tejada; Angel Navarro
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan.

Authors:  Shigeto Koizumi; Satoru Motoyama; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2017-11-14       Impact factor: 7.527

Review 5.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

6.  Gastric hyposecretion in esophageal squamous-cell carcinomas.

Authors:  K Iijima; T Koike; Y Abe; H Yamagishi; N Ara; K Asanuma; K Uno; A Imatani; N Nakaya; S Ohara; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

7.  Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.

Authors:  Katsunori Iijima; Tomoyuki Koike; Yasuhiko Abe; Nobuyuki Ara; Kaname Uno; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-05-14       Impact factor: 7.527

8.  Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis.

Authors:  Dulciene Maria Magalhães Queiroz; Gifone Aguiar Rocha; Celso Affonso de Oliveira; Andreia Maria Camargos Rocha; Adriana Santos; Mônica Maria Demas Alvares Cabral; Ana Margarida Miguel Ferreira Nogueira
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease.

Authors:  J E Richter
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease.

Authors:  P Malfertheiner
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.